Drug Database
Back to search

United Kingdom· GB-APID-37528311000001105

Renoxitin 1g powder for solution for injection vials

A cefoxitin product containing cefoxitin, registered in United Kingdom by Renascience Pharma Ltd. The same ATC class is registered in 7 of our 19 countries.

ATC J01DC01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedRenoxitin 1g powder for solution for …ATCJ01DC01REGISTER NO.GB-APID-3752831100000…PACKS LISTED1CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cefoxitinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cefoxitin is registered in 7 of 19 countries.

Countries holding a registration under ATC J01DC01 (cefoxitin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 5 of them publish a price we can compare per daily dose
Search cefoxitin products by name

Cefoxitin · ATC J01DC01

7 / 19 countries

  • Canada
  • Finlandprice
  • Franceprice
  • Norwayprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefoxitin costs, country by country.

Normalised to the WHO defined daily dose (6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Cefoxitin · price per daily dose (6 g)

USD · FX 28 Sept 2026

  • ES Spain$28.55
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Cefoxitin
Manufacturer
Renascience Pharma Ltd
Country
United Kingdom (GB)
ATC code
J01DC01
ATC class
Cefoxitin
Defined daily dose
6 g, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5060512180022

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

51 interactions on record for cefoxitin.

Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cefoxitin against other medicinesHow interaction checks work

Cefoxitin · interactions on record

51 records

  • 20 moderate
  • 2 minor
  • 29 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefoxitin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefoxitin products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Bulgaria · Цефокситин Тенамид
  • Estonia · Cefoxitin Auxilia
  • Spain · Cefoxitina Ldp-Laboratorios Torlan, Cefoxitina Normon
  • France · Cefoxitine Ldp-Laboratorios Torlan, Cefoxitine Panpharma
  • Greece · Mefoxil 2 G/Vial, Μεfoxil
  • Italy · Mefoxin
  • Portugal · Atralxitina, Cefoxitina Basi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e2ba0d96-2e9b-4207-b822-00b9fd5093bb
GET /v1/drugs/e2ba0d96-2e9b-4207-b822-00b9fd5093bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "37528311000001105",
  "desc": "Renoxitin 1g powder for solution for injection vials (Renascience Pharma Ltd)",
  "form": "Powder for solution for injection",
  "vpid": "41943611000001102",
  "source": "dmd",
  "vtm_id": "775107001",
  "strength": "1 gram",
  "substance": "Cefoxitin",
  "ingredient": "Cefoxitin sodium",
  "supplier_code": "36445211000001101"
}
API referenceMCP serverPlans

See everything about cefoxitin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console